For more than 25 years, Medtronic has been helping people with diabetes manage their glucose levels and live longer, healthier lives. We are committed to ongoing breakthrough developments in:
Leading-edge Technology
Unrivaled Service and Support
Uncompromising Leadership
Leading-edge Technology
We consistently develop and advance insulin delivery and glucose management products based on the conclusive results of extensive clinical research. Our dedication has brought the diabetes community milestone innovations such as:
The first insulin pump;
The first physician-use continuous glucose monitoring system; and
The only FDA-approved integrated diabetes management system consisting of an insulin pump, continuous glucose monitoring (CGM) and therapy management software.
Studies demonstrate this integrated system can provide superior glucose control compared to multiple daily injections (MDI) so the risk of long-term complications from diabetes can be reduced.1 It also extends our lead on the path to developing an artificial pancreas—a “closed-loop” insulin delivery system.
Today, we’re both driving towards an artificial pancreas and working to develop products that improve the lives of people with diabetes in the near-term. In each case, we’re focused on technologies that simplify diabetes management as well as help improve clinical outcomes.
IMPORTANT SAFETY INFORMATION >
Unrivaled Service and Support
Medtronic ensures the success of diabetes management therapy through comprehensive support and education at each stage of a customer’s journey. Our live HelpLine is available 24 hours a day, 7 days a week, 365 days a year. We are here to answer product support questions, provide insurance assistance and ensure that supplies arrive on time where and when you need them. With more than 2,800 Certified Product Trainers, the myLearning advanced online educational courses and local support groups, we help you get the most out of insulin pump therapy and CGM.
Uncompromising Leadership
The Diabetes business of Medtronic is one of six major businesses of Medtronic, whose medical technologies help make it possible for millions of people to resume everyday activities, return to work, and live better, longer. We're able to do this with the help of some very special people around the world: 38,000 dedicated employees who share a passionate purpose to improve lives, thousands of medical professionals who share their insights and ideas, and hundreds of advocacy associations that help us share information so people with chronic diseases know relief is possible.
We are proud of our long history of innovation and the Medtronic Mission which continues to unite all of us worldwide in a higher purpose: to alleviate pain, restore health, and extend lives.
- 1
- Bergenstal RM, Tamborlane WV, Ahmann A, et al. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med 2010; 363:311-20.
Font Size/Page Zoom